Sandoz Atorvastatin film-coated tablets

Sandoz Atorvastatin is a generic medication used to lower cholesterol and prevent cardiovascular disease. As a product of Sandoz, a global leader in generic and biosimilar medicines, it represents a cost-effective alternative to branded statins like Lipitor. The production of such generic pharmaceuticals typically occurs across a vast global network of facilities, including major manufacturing hubs in Europe, India, and North America, depending on the specific regional market and regulatory approvals.

The history of the Sandoz brand is deeply rooted in Switzerland, having been founded in Basel in the 19th century. For many years, Sandoz operated as a division of the pharmaceutical giant Novartis. However, in October 2023, Sandoz completed a strategic spin-off to become a fully independent, publicly traded company. This move allowed Sandoz to focus exclusively on its growth as a standalone generic pharmaceutical provider, headquartered in Switzerland and serving patients worldwide.